CLINICAL_TRIALS
trial_result
· 2022-04-21
Clinical Trial Update: CANA/Met in Non-diabetic Women With PCOS [Phase 1, Phase 2]
Summary
Phase 1/2 trial update evaluating CANA/Met in non-diabetic women with polycystic ovary syndrome (PCOS) has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shengjing Hospital | Conditions: Polycystic Ovary Syndrome | Phase 1, Phase 2 | Status: COMPLETED